An exploratory biomarker trial of temsirolimus in subjects with newly diagnosed advanced stage squamous cell carcinoma of the head and neck

Trial Profile

An exploratory biomarker trial of temsirolimus in subjects with newly diagnosed advanced stage squamous cell carcinoma of the head and neck

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2007

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Head and neck cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 17 Sep 2007 Status changed from in progress to completed.
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top